By integrating neurons with simulators, we've opened a completely new avenue in drug screening.
Our approach involves developing a simulator in which the entities within are controlled by neurons themselves. This setup permits multiple neural cultures, each in their own biochips, to interact within the virtual environment. By modeling symptoms or disease-specific behaviors onto these entities, we can physically test drugs on the neurons to observe their effectiveness in altering these simulated symptoms.
This approach is poised to enhance the success rates of drugs in clinical trials. By accurately correlating symptoms and behaviors to specific diseases within the simulator, we can identify underperforming drugs and screen them out before entering costly clinical trials.
This method ensures that only the most promising drugs proceed to trial, optimizing both time and resources.
To discover more about our cutting-edge screening platforms or to integrate them into your operations, we encourage you to contact us.